Corporate Banner
Satellite Banner
Technology Networks Header
Monday, December 22, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Sensitive and Simple Determination of Monochloroacetic Acid in Carbocisteine
Friday, March 14, 2014
New approach is sensitive and easier to use than other methods.

Malvern Instruments at Analytica 2014
Wednesday, March 12, 2014
Malvern Instruments shows how complementary technologies solve analytical challenges from biopharm to bulk materials.

Bio-Rad Announces New Technology for the Identification of Unknown Compounds with Infrared and Raman Spectroscopy
Tuesday, March 11, 2014
New technologies combine Bio-Rad's years of accumulated knowledge in the field of spectroscopy with advanced computational power

Phenomenex Announces New Kinetex Core-Shell Biphenyl Columns
Tuesday, March 04, 2014
Expands selectivity of Kinetex® core-shell line.

Promega Introduces GloMax Discover Multimode Detection System
Friday, January 31, 2014
New plate reader system provides superior sensitivity, performance, and flexibility with minimal user intervention.

Waters Introduces UPLC System for nano- to Microscale Separations
Wednesday, January 29, 2014
New UPLC system and columns drive separations efficiency and the sensitivity of LC-MS analyses to new levels.

LIMSABC Releases Cloud LIMS for Medical and Recreational Marijuana Testing
Monday, January 27, 2014
New company offers specialized LIMS solution

Supplying a Research Lab with Advanced Equipment Has Never Been Easier
Monday, January 20, 2014
Harvard Bioscience supplies scientific instruments to improve life science research.

The University of Paris Selects ACD/Percepta Software to Enhance Teaching and Research into Pharmaceuticals
Monday, December 16, 2013
ADME/Tox and PhysChem predictions on the Percepta Platform will help educate and train the next generation of pharmaceutical scientists.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 656
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn